Palatin Technologies snags $30 mln

By Iris Dorbian — 7 months ago

Cranbury, NJ-based biopharmaceutical firm Palatin Technologies has raised about $20 million in a private placement. QVT Financial LP and an unnamed investment fund were the backers. Also, Palatin has secured a $10 million venture loan led by Horizon Technology Finance Corp.

Continue

Palatin Technologies nets $30 mln

By Iris Dorbian — 1 year ago

Cranbury, NJ-based biopharmaceutical firm Palatin Technologies has raised $20 million in a private placement. QVT Financial and an unnamed investment fund were the investors. According to terms of the transaction, Palatin sold over 2 million shares of its common stock at $0.75 per share. Also, Palatin has secured a $10 million venture loan led by Horizon Technology Finance Corp.

Continue

Acceleron Pharma Inks $30M

4 years ago

Cambridge, Mass.-based Acceleron Pharma Inc. has raised $30 million in financing. The company said that strategic partner Celgene contributed to the round, along with “all other existing investors.” Acceleron has raised capital from Advanced Technology Ventures, Alkermes, Avalon Ventures, Bessemer Ventures, Celgene, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. The new funds will be used to expand the company’s clinical stage pipeline.

Continue